The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Melioidosis Diagnostic Workshop, 20131
Open accessAbstract
Melioidosis is a severe disease that can be difficult to diagnose because of its diverse clinical manifestations and a lack of adequate diagnostic capabilities for suspected cases.There is broad interest in improving detection and diagnosis of this disease not only in melioidosis-endemic regions but also outside these regions because melioidosis may be underreported and poses a potential bioterrorism challenge for public health authorities.Therefore, a workshop of academic, government, and private sector personnel from around the world was convened to discuss the current state of melioidosis diagnostics, diagnostic needs, and future directions.M elioidosis is a frequently fatal infection caused by the gram-negative bacillus Burkholderia pseudomallei (1).It is highly endemic to northeastern Thailand and northern Australia, where the causative organism is commonly found in soil and fresh water.Melioidosis also occurs in those who travel to disease-endemic regions of the world, which include tropical regions of Asia and South America, Central America, various Pacific and Indian Ocean islands, and some countries in Africa (1).B. pseudomallei can also cause latent infection; the longest documented interval between exposure and clinical melioidosis is 62 years (2).The crude case-fatality rate for melioidosis ranges from 14% to 40% and may be as high as 80% if effective antimicrobial drugs are not given.Clinical diagnosis of melioidosis is difficult because the disease has no pathognomonic clinical manifestations (1).The current diagnostic standard is culture; however, B. pseudomallei can be misidentified as a culture contaminant or as another species (e.g., Burkholderia cepacia, Bacillus spp., or Pseudomonas spp.), especially by laboratory staff unfamiliar with this organism (1,3-5).In addition, B. pseudomallei is categorized as a Tier 1 select agent by the US government, and special precautions are recommended to reduce the possibility of exposure while conducting bacterial culture.There are currently no commercially available and reliable rapid diagnostic tests for melioidosis.Serologic tests, such as indirect hemagglutination assay (IHA), have been widely used, but these are neither sensitive nor specific.With the goal of improving timely and accurate diagnosis of melioidosis, a workshop sponsored by the US Centers for Disease Control and Prevention was held in Bangkok, Thailand, on September 14-15, 2013, to discuss current recommendations and future research directions.International subject matter experts representing academia, government, and the private sector attended the workshop to discuss the current state of melioidosis diagnostics, diagnostic needs, and future directions.The workshop consisted of multiple sessions focused on specific diagnostic topics (e.g., culture, PCR, serology, and new methods).Each session included short presentations followed by extensive
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chapter 9: Options for Summarizing Medical Test Performance in the Absence of a “Gold Standard”
Trikalinos, T. A., & Balion, C. M. (2012) · Journal of General Internal Medicine · doi:10.1007/s11606-012-2031-7 · Cited by 59 · cited 1×
“This finding has prompted reevaluation of older serologic assays (68) and has implications for the evaluation of new diagnostic tests (69).”
Background
Cited by
Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis
Limmathurotsakul, D., Golding, N., Dance, D. A. B., Messina, J. P., Pigott, D. M., Moyes, C. L., Rolim, D. B., Bertherat, E., Day, N. P. J., Peacock, S. J., et al. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2015.8 · Cited by 1,022
Self-citationWiersinga, W. J., Virk, H. S., Torres, A. G., Currie, B. J., Peacock, S. J., Dance, D. A. B., & Limmathurotsakul, D. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.107 · Cited by 681
Self-citation
Metadata
- Authors
- Hoffmaster, A. R., AuCoin, D., Baccam, P., Baggett, H. C., Baird, R., Bhengsri, S., Blaney, D. D., Brett, P. J., Brooks, T. J. G., Brown, K. A., Chantratita, N., Cheng, A. C., Dance, D. A. B., Decuypere, S., Defenbaugh, D., Gee, J. E., Houghton, R., Jorakate, P., Lertmemongkolchai, G., Limmathurotsakul, D., Merlin, T. L., Mukhopadhyay, C., Norton, R., Peacock, S. J., Rolim, D. B., Simpson, A. J., Steinmetz, I., Stoddard, R. A., Stokes, M. M., Sue, D., Tuanyok, A., Whistler, T., Wuthiekanun, V., & Walke, H. T.
- Venue
- Emerging Infectious Diseases
- Published
- 2015-02
- Volume
- 21
- Issue
- 2
- ISSN
- 1080-6040 (ISSN-L)
- 1080-6059
- OpenAlex
- W2118377265
- Cited by
- 180
- References
- 1
- FWCI
- 13.07
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Melioidosis Diagnostic Workshop, 20131. https://app.cochat.ai/papers/10.3201/eid2102.141045
- The paper
- Hoffmaster, A. R., AuCoin, D., Baccam, P., Baggett, H. C., Baird, R., Bhengsri, S., Blaney, D. D., Brett, P. J., Brooks, T. J. G., Brown, K. A., Chantratita, N., Cheng, A. C., Dance, D. A. B., Decuypere, S., Defenbaugh, D., Gee, J. E., Houghton, R., Jorakate, P., Lertmemongkolchai, G., . . . Walke, H. T. (2015). Melioidosis Diagnostic Workshop, 20131. Emerging Infectious Diseases. https://doi.org/10.3201/eid2102.141045
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.